CA Stock MarketDetailed Quotes
TMO Thermo Fisher Scientific Inc
- 20.190
- -0.220-1.08%
15min DelayTrading Nov 12 15:30 ET
283.56BMarket Cap34.40P/E (TTM)
20.410High20.190Low50.03KVolume20.410Open20.410Pre Close1.02MTurnover23.36552wk High0.01%Turnover Ratio14.04BShares19.91752wk Low0.587EPS TTM7.71BFloat Cap23.365Historical High36.18P/E (Static)381.66MShs Float19.917Historical Low0.558EPS LYR1.08%Amplitude0.04Dividend TTM4.16P/B1Lot Size0.22%Div YieldTTM
Thermo Fisher Scientific Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 29, 2024 | (Q1)Mar 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jul 1, 2023 | (Q1)Apr 1, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.23%10.6B | -1.37%10.54B | -3.41%10.35B | -4.58%42.86B | -4.93%10.89B | -0.96%10.57B | -2.58%10.69B | -9.38%10.71B | 14.55%44.92B | 6.99%11.45B |
| Operating revenue | 0.23%10.6B | -1.37%10.54B | -3.41%10.35B | -4.58%42.86B | -4.93%10.89B | -0.96%10.57B | -2.58%10.69B | -9.38%10.71B | 14.55%44.92B | 6.99%11.45B |
| Cost of revenue | 0.19%6.27B | -3.76%6.19B | -6.54%6.14B | -0.72%25.76B | -5.13%6.49B | -1.84%6.26B | 1.02%6.44B | 3.40%6.57B | 32.55%25.94B | 25.62%6.84B |
| Gross profit | 0.28%4.33B | 2.26%4.35B | 1.57%4.21B | -9.86%17.1B | -4.62%4.39B | 0.33%4.32B | -7.57%4.25B | -24.23%4.14B | -3.40%18.97B | -12.33%4.61B |
| Operating expense | 3.21%2.44B | -1.61%2.45B | 1.99%2.51B | -6.52%9.78B | -8.59%2.46B | -7.46%2.37B | -3.26%2.49B | -6.66%2.47B | 11.17%10.46B | 0.75%2.69B |
| Selling and administrative expenses | 2.39%2.1B | -1.59%2.11B | 3.02%2.18B | -6.09%8.45B | -7.26%2.13B | -7.20%2.05B | -2.90%2.15B | -6.94%2.12B | 12.31%8.99B | 0.92%2.3B |
| Research and development costs | 8.46%346M | -1.74%339M | -4.34%331M | -9.11%1.34B | -16.37%327M | -9.12%319M | -5.48%345M | -4.95%346M | 4.62%1.47B | -0.26%391M |
| Operating profit | -3.29%1.88B | 7.72%1.9B | 0.96%1.69B | -13.98%7.32B | 0.94%1.93B | 11.76%1.95B | -13.04%1.76B | -40.67%1.68B | -16.80%8.51B | -25.85%1.92B |
| Net non-operating interest income (expenses) | 30.09%-79M | 60.14%-59M | 45.45%-84M | -9.25%-496M | 31.93%-81M | -7.62%-113M | -32.14%-148M | -30.51%-154M | 7.91%-454M | 20.67%-119M |
| Non-operating interest income | 12.60%277M | 65.73%295M | 91.10%279M | 223.16%879M | 106.00%309M | 261.76%246M | 394.44%178M | 711.11%146M | 532.56%272M | 1,263.64%150M |
| Non-operating interest expense | -0.84%356M | 8.59%354M | 21.00%363M | 89.39%1.38B | 44.98%390M | 107.51%359M | 120.27%326M | 120.59%300M | 35.45%726M | 67.08%269M |
| Other net income (expenses) | 12.86%-61M | 60.66%-72M | 87.97%-19M | -140.37%-524M | -465.00%-113M | -89.19%-70M | -4,675.00%-183M | 4.24%-158M | 75.53%-218M | 96.50%-20M |
| Special income (charges) | 46.43%-45M | 57.92%-77M | 74.11%-29M | -302.63%-459M | -45.45%-80M | -154.55%-84M | -662.50%-183M | -5,500.00%-112M | 42.13%-114M | -19.57%-55M |
| -Less:Restructuring and mergern&acquisition | -46.43%45M | -57.92%77M | -74.11%29M | 302.63%459M | 45.45%80M | 154.55%84M | 662.50%183M | 5,500.00%112M | -42.13%114M | 19.57%55M |
| Other non-operating income (expenses) | -214.29%-16M | --5M | 121.74%10M | 37.50%-65M | -194.29%-33M | 450.00%14M | ---- | 71.78%-46M | 85.01%-104M | 106.65%35M |
| Income before tax | -1.30%1.74B | 23.43%1.77B | 16.58%1.59B | -19.62%6.3B | -2.08%1.74B | 10.24%1.77B | -25.40%1.43B | -46.34%1.36B | -11.38%7.84B | -4.56%1.78B |
| Income tax | 86.79%99M | 146.15%128M | 510.87%281M | -59.60%284M | -23.12%133M | 70.97%53M | -73.74%52M | -84.72%46M | -36.61%703M | -14.78%173M |
| Earnings from equity interest net of tax | 17.65%-14M | -425.00%-84M | 192.00%23M | 65.70%-59M | 96.67%-1M | 76.39%-17M | 68.63%-16M | -31.58%-25M | -4,200.00%-172M | -30M |
| Net income | -3.89%1.63B | 14.02%1.55B | 3.02%1.33B | -14.44%5.96B | 2.03%1.61B | 13.15%1.7B | -18.35%1.36B | -41.80%1.29B | -9.94%6.96B | -5.12%1.57B |
| Net income continuous operations | -3.89%1.63B | 14.02%1.55B | 3.02%1.33B | -14.44%5.96B | 2.03%1.61B | 13.15%1.7B | -18.35%1.36B | -41.80%1.29B | -9.94%6.96B | -5.12%1.57B |
| Noncontrolling interests | 0 | 500.00%6M | 33.33%4M | -500.00%-40M | -1,100.00%-24M | -766.67%-20M | -75.00%1M | -40.00%3M | 233.33%10M | -300.00%-2M |
| Net income attributable to the company | -4.96%1.63B | 13.74%1.55B | 3.03%1.33B | -13.74%6B | 3.43%1.63B | 14.72%1.72B | -18.21%1.36B | -41.81%1.29B | -10.03%6.95B | -4.95%1.58B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -4.96%1.63B | 13.74%1.55B | 3.03%1.33B | -13.74%6B | 3.43%1.63B | 14.72%1.72B | -18.21%1.36B | -41.81%1.29B | -10.03%6.95B | -4.95%1.58B |
| Diluted earnings per share | -4.05%0.116 | 14.73%0.1103 | 3.89%0.0945 | -12.56%0.4227 | 4.72%0.1149 | 16.23%0.1209 | -16.94%0.0961 | -40.99%0.091 | -9.53%0.4834 | -4.05%0.1098 |
| Basic earnings per share | -3.85%0.1157 | 15.10%0.11 | 4.22%0.0942 | -12.37%0.4208 | 4.74%0.1144 | 16.62%0.1204 | -16.83%0.0956 | -40.82%0.0904 | -9.40%0.4801 | -3.84%0.1092 |
| Dividend per share | 0.0109 | 0.0105 | 0.011 | |||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data